+47.2%
CVS vs AMGN
+302.3%
-255.1%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | AMGN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -1.1% | -0.5% | -1.2% |
| 7D | -10.9% | -6.0% | -4.8% | -8.7% |
| 30D | -14.9% | 0.0% | -14.9% | -15.2% |
| 3M | -13.9% | -0.2% | -13.7% | -14.5% |
| 6M | -13.9% | +33.4% | -47.3% | -23.8% |
| YTD | +4.0% | +36.8% | -32.9% | -9.7% |
| 1Y | +7.8% | +31.7% | -23.9% | -5.1% |
| 3Y | +30.2% | +79.5% | -49.2% | -2.7% |
| 5Y | +1.6% | +146.7% | -145.2% | -36.1% |
| All | +47.2% | +302.3% | -255.1% | -21.3% |
Cumulative growth
Daily Returns
Daily percentage return beside AMGN.
Daily Out/Under-Performance
Portfolio return minus AMGN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMGN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded AMGN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling